Sign Up Today and Learn More About Spyglass Pharma Stock
Invest in or calculate the value of your shares in Spyglass Pharma or other pre-IPO companies through EquityZen's platform.
Spyglass Pharma Stock (SPPH)
Spyglass Pharma provides medicine for ophthalmic diseases.
About Spyglass Pharma Stock
Founded
2019
Headquarters
Aliso Viejo, CA, US
Industries
Software, Artificial Intelligence, Data and Analytics
Spyglass Pharma Press Mentions
Stay in the know about the latest news on Spyglass Pharma
SpyGlass Pharma Completes Enrollment in Phase I/II Study of its Promising Long-Term Drug Delivery Platform for Glaucoma and Ocular Hypertension
globenewswire • Nov 19, 2024
SpyGlass Pharma Unveils Compelling 1-Year Data of Its Innovative Drug Delivery Platform Implanted During Routine ...
globenewswire • May 24, 2024
Intraocular drug delivery systems and methods of use
patents • Apr 15, 2024
Intraocular drug delivery systems and methods of use
patents • Apr 15, 2024
Stabilized intraocular drug delivery systems and methods of use
patents • Apr 15, 2024
Spyglass Pharma Management
Leadership team at Spyglass Pharma
Co-Founder and CTO
Glenn Sussman
CEO
Patrick Mooney
Join now and verify your accreditation status to gain access to:
- Spyglass Pharma current valuation
- Spyglass Pharma stock price
- Available deals in Spyglass Pharma and all other companies
- Deal offering documents
- EquityZen's proprietary data and insights, including
- Cap tables, which include funding history by Share Class and Liquidity Preferences
- Company Highlights
- Business Model
- Risk Factors
How to invest in Spyglass Pharma stock?
Accredited investors can buy pre-IPO stock in companies like Spyglass Pharma through EquityZen funds. These investments are made available by existing Spyglass Pharma shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.
How to sell Spyglass Pharma stock?
Shareholders can sell their Spyglass Pharma stock through EquityZen's private company marketplace. EquityZen's network includes over 330K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.
If I invest, how do I exit my investment?
There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.
Why choose EquityZen?
Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 43K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."
